Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-HT2B receptor is a G protein-coupled receptor (GPCR) primarily coupled to Gq/11, mediating diverse physiological functions. It plays a significant role in cardiac structure and function, vascular regulation, and neurotransmitter modulation in the CNS. A critical concern is its involvement in drug-induced valvular heart disease, making it an important off-target consideration in drug development for serotonergic agents. Overstimulation leads to pathological proliferation of cardiac valve fibroblasts leading to valvulopathy.
Gq/11 protein activation; stimulates phospholipase Cβ (PLCβ); generates diacylglycerol (DAG) & IP₃; increases intracellular Ca²⁺; activates protein kinase C (PKC)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor Subtype 2B (5-HT2B).